EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

183 hedge funds and large institutions have $1.16B invested in Eagle Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
183
Holders Change
+9
Holders Change %
+5.17%
% of All Funds
4.2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
31
Increased
57
Reduced
60
Closed
21
Calls
$14.8M
Puts
$14.4M
Net Calls
+$347K
Net Calls Change
-$380K

Top Buyers

1
RCAMU
Rothschild & Co Asset Management US
Connecticut
+$30.8M
2
CCM
Camber Capital Management
Massachusetts
+$19.8M
3
BlackRock
BlackRock
New York
+$13.9M
4
CIP
Chartwell Investment Partners
Pennsylvania
+$12.1M
5
GIP
Granite Investment Partners
California
+$6.4M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$26.6M
2
JIM
Jupiter Investment Management
United Kingdom
-$24.7M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$20.8M
4
LSV Asset Management
LSV Asset Management
Illinois
-$20.2M
5
Prudential Financial
Prudential Financial
New Jersey
-$13.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
SWP
201
Stratos Wealth Partners
Ohio
– -$29K -550 Closed
GXMC
202
Global X Management Company
New York
– -$19K -352 Closed
Group One Trading
203
Group One Trading
Illinois
– -$10K -190 Closed
5 6 7 8
9